Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AX vs AC in Node-Negative Breast Cancer
NCT01415336Phase 3Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2010
- Primary completion
- Mar 2013
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in breast cancer, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
capecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01415336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415336.